Activity of telithromycin against erythromycin-susceptible and -resistant Streptococcus pneumoniae isolates from adults with invasive infections

International Journal of Antimicrobial Agents

Volumn 24, Issue 6, 2004, Pages 616-618

  Ortega, Mar ^a   Marco, Francesc ^a   Almela, Manel ^a   Puig, Jorge ^a   Soriano, Alex ^a   Mensa, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Bactericidal activity; S. pneumoniae; Telithromycin; Time kill curves

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; TELITHROMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SENSITIVITY; HUMAN; INCUBATION TIME; KINETICS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TIME;

ADULT; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; KETOLIDES; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 8844243351     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.06.018     Document Type: Article

References (10)

1. I.R. Friedland, and G.H. McCraken Management of infections caused by antibiotic-resistant Streptococcus pneumoniae N. Engl. J. Med. 331 1994 377 382
2. M.R. Jacobs Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae Clin. Infect. Dis. 15 1992 119 127
3. P.C. Appelbaum Resistance among Streptococcus pneumoniae: implications for drug selection Clin. Infect. Dis. 34 2002 1613 1620
4. P. Geslin, A. Fremaux, G. Sissia, C. Spicq, and A. Aberrane Epidémiologie de la résistance aux antibiotiques de Streptococcus pneumoniae en France Réseau national de surveillance Méd. Mal. Infect. 24 1994 948 961
5. A.L. Barry, M.A. Pfaller, P.C. Fuchs, and R.R. Packer In vitro activities of 12 orally administrated antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993 Antimicrob. Agents Chemother. 38 1994 2419 2425
6. E. Bingen, C. Doit, and C. Loukil Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections Antimicrob. Agents Chemother. 47 2003 2345 2347
7. G.A. Pankuch, M.A. Visalli, M.R. Jacobs, and P.C. Appelbaum Susceptibilities of penicillin- and erythromycin-susceptible and -resistant pneumococci to HMR 3647 RU 66647 a new ketolide, compared with susceptibilities to 17 other agents Antimicrob. Agents Chemother. 42 1998 624 630
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing, 12th informational supplement. Document M100-S12. Wayne (PA): National Committee for Clinical Laboratory Standards; 2002.
9. M.I. Morosini, R. Cantón, and E. Loza In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms Antimicrob. Agents Chemother. 45 2001 2427 2431
10. G. Ackermann, and A.C. Rodloff Drugs of the 21st century: telithromycin (HMR 3647) the first ketolide J. Antimicrob. Chemother. 51 2003 497 511